Previous 10 | Next 10 |
2023-11-09 10:34:09 ET GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Conference Call November 09, 2023, 08.00 AM ET Company Participants Whitney Notaro - VP, IR Scott Wagner - Interim CEO Karsten Voermann - CFO Raj Beri - COO Conference Call Participant...
2023-11-09 06:09:10 ET More on GoodRx Holdings GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In GoodRx Stock: Earnings Momentum Keeps It Interestin GoodRx to offer Sanofi’s Lantus insulin product at $35 Seeking Al...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, has released its financial results for the third quarter 2023. Third Quarter 2023 Highlights Revenue 1 of $180.0 million...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
GoodRx Holdings Inc. (GDRX) is expected to report $0.01 for Q3 2023
2023-11-08 12:49:27 ET More on GoodRx Holdings GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In GoodRx Stock: Earnings Momentum Keeps It Interesting GoodRx to offer Sanofi’s Lantus insulin product at $35 GoodRx, d...
2023-11-05 12:00:34 ET More on Amwell, Teladoc Health, etc. American Well Corporation (AMWL) Q3 2023 Earnings Call Transcript Teladoc Q3 Earnings: Difficult Quarter, Tough Outlook, Slight Hopes Of A Turnaround Teladoc Health: Don't Fall For The Market's Profit Obsess...
2023-10-26 11:48:56 ET More on Teladoc Health Teladoc Q3 Earnings: Difficult Quarter, Tough Outlook, Slight Hopes Of A Turnaround Teladoc Health: Don't Fall For The Market's Profit Obsession Teladoc Was Obliterated Teladoc drags digital health after Q3 miss ...
2023-10-26 11:48:56 ET More on Teladoc Health Teladoc Q3 Earnings: Difficult Quarter, Tough Outlook, Slight Hopes Of A Turnaround Teladoc Health: Don't Fall For The Market's Profit Obsession Teladoc Was Obliterated Teladoc drags digital health after Q3 miss ...
2023-10-25 10:49:08 ET More on AmWell, Teladoc, etc. Teladoc Health, Inc. (TDOC) Q3 2023 Earnings Call Transcript Teladoc Looks Ill As Amazon Threat Looms Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade) Biggest stock movers today: Snap, A...
News, Short Squeeze, Breakout and More Instantly...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® PR Newswire First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and S...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...
Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...